How quickly do two bowel disease treatments work for Crohn's patients

This study is tracking how quickly two different biologic medications—vedolizumab and IL-23 antagonists—help people with active Crohn's disease feel better. Researchers want to understand the speed at which these treatments reduce pain and symptoms, because both patients and doctors care deeply about rapid relief. The study will follow 300 people as they start one of these medications as part of their regular medical care.

There's a common belief that vedolizumab works more slowly than other similar treatments, but this perception may not be accurate when you look at how the medication is actually used in real practice. By carefully tracking how quickly patients improve on these treatments, researchers hope to give patients and doctors better information to make treatment decisions.